[A new medium with an agarose base for the determination of antibiotics by diffusion methods].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to J Beck.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Tampons have been associated with toxic shock syndrome, a newly-recognized disease which attacks women of menstrual age and has caused at least 84 deaths so far. A study of the medical literature since 1933, when tampons were first put on the market, reveals warning of possible dangers as a foreign body, as an irritant, as a carrier of bacteria. Today more health professionals are aware of the dangers of tampon use, but they have not yet applied this knowledge to diseases other than TSS. We believe this should be done. Tampons, now considered a Class II Medical Device, should be re-classified into Class III, where pre-market testing is mandatory.
Explore the source record for details and available documents.
We studied 24 patients with rheumatoid arthritis and 24 age- and sex-matched controls for lymphocyte subpopulations in the peripheral blood. Patients with rheumatoid arthritis had a significantly lower relative lymphocyte count (p < 0.005) and a higher percentage of T lymphocytes bearing Fc-receptor for IgM (TM) (p < 0.05). The proportion of B lymphocytes, total T lymphocytes and T lymphocytes with Fc-receptors for IgG (TG) in patients with rheumatoid arthritis was not different from that in controls. In 1 of 5 cases tested incubation of T lymphocytes in autologous rheumatoid factor positive serum instead of FCS resulted in significant reduction of TM and increase in TG cells. These results are discussed in relation to possible immunological factors involved in the etiology of rheumatoid arthritis.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
We investigated whether the expression of protein kinase C (PKC) isoenzymes, topoisomerase II alpha, II beta, multidrug resistance associated protein (MRP), p53 or the activity of glutathione-S- transferase (GST) are additional factors contributing to the resistance mediated by multidrug resistance gene 1 (mdr 1). the cell lines employed for these studies were human lymphoblastoid CCRF cells selected for resistance with actinomycin D, vincristine and adriamycin, KB-3-1 and matched resistant KB-8-5 and KB-C1 cells (selected with colchicine), and a HeLa cell line, in which the resistance was obtained by transfection with the mdr1-gene. Analysis of PKC isozymes showed that there is no correlation of a specific isoenzyme with resistance, although minor differences in the expression were observed. In vincristine and adriamycin selected cells, topoisomerase II alpha- and II beta-MRNA levels were reduced, and in vincristine selected cells the MRP-mRNA was elevated compared with the sensitive line. In KB cells the levels of topoisomerase II alpha and II beta mRNA were increasing with the resistance. Expression of p53 did not correlate with Pgp levels. In summary, MRP and topoisomerase II may contribute to the mdr1 -mediated resistance in some cell lines, but PKC, p53 and GST seem to be of minor or no importance.
Patients who develop mixed hematopoietic chimerism (MHC) after allogeneic bone marrow transplantation (allo-BMT) might have an increased risk of relapse or graft failure. In order to identify patients with MHC we established a quantitative polymerase chain reaction (PCR) approach to estimate the individual degree of autologous recovery and investigate the dynamics of MHC posttransplant. Therefore standardized mixed chimeric samples were generated in each individual case by mixing pretransplant recipient and donor DNA at a range of percentages. After amplification the samples were analyzed densitometrically and signal intensities were taken as the basis of individual standard curves. Subsequently posttransplant DNA samples were also analyzed, the intensity of the informative signals were compared to the standard curves and autologous recovery was expressed in percentage related to host DNA. We investigated 40 pediatric patients receiving allo-BMT by this method. 10/40 developed MHC during course of the observation period. Each patient with MHC revealed a certain dynamic. This approach might be helpful when deciding on early intervention and additional treatment to prevent graft failure or relapse.